THE INDIAN PHARMACIST Official Circular Pharmacy Logo THE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
MEDICINE MONOGRAPH CODE: [8.31] ID: TIP-MED-000159

Albendazole & Mebendazole

Active Ingredient / Scientific Identity: Albendazole & Mebendazole • Class: Benzimidazole Beta-Tubulin Polymerisation Inhibitor Anthelmintics (Schedule H | NLEM 2022)

⚖️ Compare Profile
Generic / Entity NameAlbendazole & Mebendazole ([8.31])
Verified Indian Brands / RefGeneric Compendial Entry (No Commercial Brand Claimed)
Pharmacological ClassBenzimidazole Beta-Tubulin Polymerisation Inhibitor Anthelmintics (Schedule H | NLEM 2022)
Available Dosage FormsAlbendazole Chewable Tablet: 400 mg; Oral Suspension: 200 mg/5 mL (10 mL bottle = 400 mg). Mebendazole Tablet:
Regulatory ClassificationSchedule H Prescription Drug (To be sold by retail on the prescription of a Registere
Key Warning & Review DateRenal: No adjustment needed. Hepatic: Monitor LFTs and CBC every 2 weeks during multi-week NCC/Hydatid courses; avoid in cirr
Reviewed: 2026-11-10
Safety Matrix:⚖️ Legal Status: Schedule H Prescription Drug (To be sold by retail o✔️ Standard Clinical Dispensing Precautions

1. Clinical & Scientific Overview

Albendazole & Mebendazole (TIP-MED-000159, Reference Code [8.31]) is classified under Antimicrobials — Antimalarial & Anthelmintic Agents (Ch 08) as a Benzimidazole Beta-Tubulin Polymerisation Inhibitor Anthelmintics (Schedule H | NLEM 2022). Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).

Verified Indian Market Examples / Compendial Status:
Representative Indian Market Examples (Edition 2.7 Ch 08 [8.31], p. 108): Albendazole: Zentel (GSK), Bandy (Mankind), Noworm (Alkem), Abd (Intas). Mebendazole: Mebex (Cipla), Wormin (Cadila) — Strengths & Dosage Forms: Albendazole Chewable Tablet: 400 mg; Oral Suspension: 200 mg/5 mL (10 mL bottle = 400 mg). Mebendazole Tablet: 100 mg, 500 mg; Suspension: 100 mg/5 mL
Representative Indian Market Examples (Edition 2.7 Ch 08 [8.31], p. 108): Albendazole: Zentel (GSK), Bandy (Mankind), Noworm (Alkem), Abd (Intas). Mebendazole: Mebex (Cipla), Wormin (Cadila) — Strengths & Dosage Forms: Albendazole Chewable Tablet: 400 mg; Oral Suspension: 200 mg/5 mL (10 mL bottle = 400 mg). Mebendazole Tablet: 100 mg, 500 mg; Suspension: 100 mg/5 mL
Dosage Forms & Available Strengths:
Albendazole Chewable Tablet: 400 mg; Oral Suspension: 200 mg/5 mL (10 mL bottle = 400 mg). Mebendazole Tablet: 100 mg, 500 mg; Suspension: 100 mg/5 mL
Routes: Oral / Parenteral / Topical as specified by formulation

3. Mechanism of Action & Pharmacodynamics

Benzimidazole Beta-Tubulin Polymerisation Inhibitor Anthelmintics (Schedule H | NLEM 2022) acting on target receptor/enzyme pathways in Antimicrobials — Antimalarial & Anthelmintic Agents (Ch 08): clinical efficacy is mediated via Benzimidazole Beta-Tubulin Polymerisation Inhibitor Anthelmintics (Schedule H | NLEM 2022) for Ascariasis (roundworm), Enterobiasis (pinworm/threadworm), Ancylostomiasis (hookworm), Trichuriasis (whipworm), National Deworming Day prophylaxis; Albendazole is also used long-term for Neurocysticercosis (NCC) and Hydatid Disease.

4. Therapeutic Indications & Evidence-Supported Uses

  • Ascariasis (roundworm), Enterobiasis (pinworm/threadworm), Ancylostomiasis (hookworm), Trichuriasis (whipworm), National Deworming Day prophylaxis
  • Albendazole is also used long-term for Neurocysticercosis (NCC) and Hydatid Disease

🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.

5. Educational Dosage Context, Formulations & Administration

Educational Dosing & Regimen Summary: Intestinal Nematodes (Adults & Children >2 yr): Albendazole 400 mg PO SINGLE DOSE (Children 1–2 yr: 200 mg [5 mL] single dose; for pinworm, repeat 400 mg once after 2 weeks; for Trichuriasis/strongyloidiasis, 400 mg OD x 3 days); OR Mebendazole 100 mg PO BD x 3 days. Neurocysticercosis: Albendazole 15 mg/kg/day (max 800 mg/d) for 8–28 days WITH Corticosteroids!

Administration & Meal Timing: DUAL FOOD RULE (LUMINAL VS. SYSTEMIC): (1) For intestinal worms (luminal action): take on an empty stomach (chew tablet thoroughly); (2) For tissue parasites (Neurocysticercosis / Hydatid cyst / Cutaneous larva migrans): MUST take WITH A FATTY MEAL (increases systemic absorption 5-fold!). Always CHEW or crush the 400 mg tablet for young children! | Single bedtime/evening dose (Intestinal Deworming); Morning & Evening with fatty meals (Neurocysticercosis/Hydatid)

6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment

Absorption & Disposition:
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Metabolism & Biotransformation:
Renal: No adjustment needed. Hepatic: Monitor LFTs and CBC every 2 weeks during multi-week NCC/Hydatid courses; avoid in cirrhosis
Elimination & Renal Adjustment:
Renal: No adjustment needed. Hepatic: Monitor LFTs and CBC every 2 weeks during multi-week NCC/Hydatid courses; avoid in cirrhosis
Hepatic Impairment Considerations:
Renal: No adjustment needed. Hepatic: Monitor LFTs and CBC every 2 weeks during multi-week NCC/Hydatid courses; avoid in cirrhosis

7. Contraindications, Precautions & High-Risk Warnings

Contraindications & Red-Flag Precautions:
  • CONTRAINDICATED in the 1st trimester of pregnancy (single-dose Albendazole 400 mg is given ONLY in the 2nd or 3rd trimester for hookworm anaemia prophylaxis!). In Neurocysticercosis, NEVER start Albendazole without pre-medicating with Dexamethasone/Prednisolone and Antiepileptics (dying brain cysts trigger fatal cerebral oedema!) and exclude ocular cysticercosis by fundoscopy first!

Key Clinical Precautions: Renal: No adjustment needed. Hepatic: Monitor LFTs and CBC every 2 weeks during multi-week NCC/Hydatid courses; avoid in cirrhosis

8. Adverse Effects Profile

Common & Mechanism-Related Adverse Effects:
  • Mild epigastric discomfort, nausea, headache, dizziness
  • In long-term high-dose therapy (NCC/Hydatid): Bone marrow suppression (agranulocytosis, aplastic anaemia, pancytopenia), hepatotoxicity, reversible alopecia, acute intracranial hypertension/seizures (from dying NCC cysts)
Serious / Dose-Limiting Adverse Effects:
  • Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.

9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions

  • Dexamethasone, Praziquantel, and Cimetidine increase plasma Albendazole sulfoxide levels by 50%; Carbamazepine, Phenytoin, and Phenobarbital decrease Albendazole sulfoxide levels by 50% in NCC!

10. Clinical Monitoring, Patient Counselling & Storage

Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.

Pharmacist Patient Counselling Points:

  • Patient Counselling Checklist: Chew the Zentel/Bandy tablet well before swallowing (never give a whole tablet to a small child under 5 years — use the 10 mL liquid!); for pinworms (perianal night itching), treat all family members on the same day, clip fingernails short, wash bedsheets in hot water, and repeat 1 tablet after 14 days
  • Meal & Clock Timing Instruction: DUAL FOOD RULE (LUMINAL VS. SYSTEMIC): (1) For intestinal worms (luminal action): take on an empty stomach (chew tablet thoroughly); (2) For tissue parasites (Neurocysticercosis / Hydatid cyst / Cutaneous larva migrans): MUST take WITH A FATTY MEAL (increases systemic absorption 5-fold!). Always CHEW or crush the 400 mg tablet for young children! (Single bedtime/evening dose (Intestinal Deworming); Morning & Evening with fatty meals (Neurocysticercosis/Hydatid))
  • Missed Dose Protocol: Single-dose deworming
  • Geriatric Dispensing Pearl: Safe in older adults

Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Albendazole Chewable Tablet: 400 mg; Oral Suspension: 200 mg/5 mL (10 mL bottle = 400 mg). Mebendazole Tablet: 100 mg, 500 mg; Suspension: 100 mg/5 mL

11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)

THE 12-STEP ORAL DRUG JOURNEY THROUGH THE HUMAN BODY (LADME) Note: IV bolus enters Step 6 directly (F = 100%); Sublingual & Transdermal routes bypass Step 4–5 Portal First-Pass Metabolism 1. Oral Administration • Tablet / Capsule swallowed • Gastric emptying to duodenum pH 1.5–3.5 (Stomach) 2. Disintegration & Dissolution • Tablet breaks into granules • API dissolves in GI fluid Noyes-Whitney Dissolution Rate 3. GI Epithelial Absorption • Crosses intestinal villi • Passive / Active / P-gp efflux Small Intestine (Large Surface Area) 4. Portal Circulation • Mesenteric veins → Portal vein • Delivers blood to liver sinusoids Pre-systemic Venous Conduit 5. First-Pass Metabolism • Gut & hepatic CYP450 extraction • High: GTN, Propranolol, Morphine Determines Bioavailability (F = f_a × (1-E_H)) 6. Systemic Circulation • Hepatic vein → IVC → Heart • Unbound vs Albumin-bound drug Only FREE drug is active 7–8. Tissue Distribution (Vd) • Capillary permeation to organs • Blood-Brain & Placental barriers Vd = Dose / C_0 (L or L/kg) 9. Target Site of Action • Receptors (GPCR, Ion channel) • Enzymes & Carrier Transporters Pharmacodynamic Effect (E_max, EC50) 10. Hepatic Biotransformation • Phase I (CYP450 Oxidation/Hydrolysis) • Phase II (Glucuronidation/Sulfation) Converts lipophilic drug → hydrophilic metabolite 11. Renal & Biliary Elimination • Nephron: Filtration + Secretion − Reabsorption • Biliary excretion & Enterohepatic recycling Total Clearance CL_tot = CL_renal + CL_hepatic 12. Excretion from the Body • Urine (Primary polar metabolite route) • Bile/Faeces, Expired Air, Sweat, Milk Elimination Half-Life t1/2 = (0.693 × Vd) / CL
svg-v339-01-adme-12-step-journey — 8.1 Complete 12-Step Journey of an Orally Administered Drug (ADME): Figure 8.1: The 12-step physiological journey of a typical orally administered solid dosage form through Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME). Note: Parenteral (IV), sublingual, and inhalational routes bypass gastrointestinal absorption and/or hepatic first-pass metabolism.

12. Authoritative References, Regulatory Sources & Editorial Disclaimer

Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 08 [8.31] (p. 108)

Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)

Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT

Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.